BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
9 results:

  • 1. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
    Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
    Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
    Fallah J; Brave MH; Weinstock C; Mehta GU; Bradford D; Gittleman H; Bloomquist EW; Charlab R; Hamed SS; Miller CP; Dorff SE; Chambers WA; Mixter BD; Dinin J; Pierce WF; Ricks TK; Tang S; Donoghue M; Pazdur R; Amiri-Kordestani L; Ibrahim A; Beaver JA
    Clin Cancer Res; 2022 Nov; 28(22):4843-4848. PubMed ID: 35727604
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism.
    Liu A; Zhou Y; Zhao T; Tang X; Zhou B; Xu J
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):343-357. PubMed ID: 33993382
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of pancreatic Neuroendocrine Tumors.
    Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
    Front Immunol; 2021; 12():654660. PubMed ID: 33968055
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis.
    Liu A; Xu J
    Clin Transl Oncol; 2021 Sep; 23(9):1905-1914. PubMed ID: 33864618
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patient-Reported Quality of Life Before and After Chemoradiation for Intact Pancreas cancer: A Prospective Registry Study.
    Breen WG; Jethwa KR; Yu NY; Spears GM; Harmsen WS; Miller RC; Ashman JB; Rule WG; Sio TT; Neben-Wittich MA; Haddock MG; Mahipal A; Truty MJ; Hallemeier CL; Merrell KW
    Pract Radiat Oncol; 2021; 11(1):e63-e69. PubMed ID: 32712461
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systemic but not MDSC-specific irf4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
    Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
    Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preliminary Kidney Parenchymal Ligation Using Endoloop Ligatures-A Simple Method to Achieve a Trifecta in Laparoscopic Partial Nephrectomy Without Hilar Clamping for Polar Complex Tumors.
    Komai Y; Gotohda N; Matsubara N; Takeda H; Yuasa T; Inoue M; Yamamoto S; Yonese J
    Urology; 2018 Nov; 121():182-188. PubMed ID: 30171918
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
    Innocenti F; Owzar K; Jiang C; Etheridge AS; Gordân R; Sibley AB; Mulkey F; Niedzwiecki D; Glubb D; Neel N; Talamonti MS; Bentrem DJ; Seiser E; Yeh JJ; Van Loon K; McLeod H; Ratain MJ; Kindler HL; Venook AP; Nakamura Y; Kubo M; Petersen GM; Bamlet WR; McWilliams RR
    PLoS One; 2018; 13(8):e0202272. PubMed ID: 30107003
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.